Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 5Recurrence 4Neoplasm Metastasis 4Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, B-Cell 2Head and Neck Neoplasms 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Smoking 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Oligodendroglioma 1Neuralgia 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Laryngeal Diseases 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1

Interventions

Lidocaine 2Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcranial Magnetic Stimulation 1Paclitaxel 1Oxaliplatin 1Lidoderm 1Geritol 1Gabapentin 1Folfox protocol 1Drug Therapy 1Docetaxel 1Cisplatin 1Calcium Dobesilate 1Bupivacaine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neuralgia × Vitamin B 12 × Clear all
NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

New Mexico Cancer Research Alliance

Phase 3 Completed
319 enrolled 7 charts

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡